The activity of a new oxazolidinone antimicrobial, AZD2563, was assessed against >500 clinical isolates of enterococci representing six species. All isolates, including those resistant to other antibiotic classes, were inhibited by AZD2563 at concentrations </=2 micro g/ml, except for four strains resistant to linezolid. In most cases, AZD2563 was twofold more active than linezolid against enterococci.
No takes yet. Share an insight, caveat, or question.
Eliopoulos et al. (2002) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: